Abu Dhabi: Abu Dhabi Stem Cells Center (ADSCC) and Yas Clinic have been granted a highly regarded global accreditation by AABB (formerly known as the American Association of Blood Banks) for Hematopoietic Progenitor Cell Collection.
According to Emirates News Agency, Prof Yendry Ventura, Chief Executive Officer of ADSCC and Adjunct Professor at United Arab Emirates University, emphasized that achieving AABB accreditation marks a significant milestone in their commitment to excellence in cellular therapies. As the first institution in the UAE to receive this prestigious accreditation, ADSCC continues to set new benchmarks in quality and patient safety, backed by solid infrastructure, a state-of-the-art apheresis and ECP unit, and unparalleled clinical expertise.
This achievement underscores ADSCC's dedication to pioneering cutting-edge treatments, enhancing healthcare standards, and reinforcing the UAE's position as a regional leader in regenerative medicine and biological sciences.
Dr. Maysoon Al Karam, Chief Medical Officer at Yas Clinic operated by ADSCC, stated that this achievement reflects the efforts and expertise of their entire team, including scientists, haematologists, immunologists, nurses, and technicians. Being one of only two AABB-accredited facilities in the MENA region for HPC collection is a significant milestone for their patients and physicians, contributing to the advancement of cellular therapy in the UAE and beyond.
AABB's accreditation program is the leader in ensuring the highest level of quality and safety for the blood and biotherapies field. It promotes the highest standards of care for patients, donors, processes, and products in all aspects of transfusion medicine, biotherapies, and relationship testing.